Mirta Schattner, Instituto de Medicina Experimental, CONICET-ANM, Pacheco de Melo 3081, Buenos Aires 1425, Argentina, Tel.: +54 11 4805 5759 ext. 301, Fax: +54 11 4805 0712, E-mail:
Thromb Haemost. 2013 Nov;110(5):1035-45. doi: 10.1160/TH13-02-0174. Epub 2013 Aug 22.
Histones are highly alkaline proteins found in cell nuclei and they can be released by either dying or inflammatory cells. The recent observations that histones are major components of neutrophil extracellular traps and promote platelet aggregation and platelet-dependent thrombin generation have shown that these proteins are potent prothrombotic molecules. Because the mechanism(s) of platelet activation by histones are not completely understood, we explored the ability of individual recombinant human histones H1, H2A, H2B, H3 and H4 to induce platelet activation as well as the possible molecular mechanisms involved. All histones were substrates for platelet adhesion and spreading and triggered fibrinogen binding, aggregation, von Willebrand factor release, P-selectin and phosphatidylserine (PS) exposure and the formation of platelet-leukocyte aggregates; however, H4 was the most potent. Histone-mediated fibrinogen binding, P-selectin and PS exposure and the formation of mixed aggregates were potentiated by thrombin. Histones induced the activation of ERK, Akt, p38 and NFκB. Accordingly, histone-induced platelet activation was significantly impaired by pretreatment of platelets with inhibitors of ERK (U 0126), PI3K/Akt (Ly 294002), p38 (SB 203580) and NFκB (BAY 11-7082 and Ro 106-9920). Preincubation of platelets with either aspirin or dexamethasone markedly decreased fibrinogen binding and the adhesion mediated by histones without affecting P-selectin exposure. Functional platelet responses induced by H3 and H4, but not H1, H2A and H2B, were partially mediated through interaction with Toll-like receptors -2 and -4. Our data identify histones as important triggers of haemostatic and proinflammatory platelet responses, and only haemostatic responses are partially inhibited by anti-inflammatory drugs.
组蛋白是存在于细胞核中的高度碱性蛋白质,它们可以由死亡或炎症细胞释放。最近的观察表明,组蛋白是中性粒细胞胞外诱捕网的主要成分,并促进血小板聚集和血小板依赖的凝血酶生成,这表明这些蛋白质是强有力的促血栓形成分子。由于组蛋白激活血小板的机制尚不完全清楚,我们探索了单个重组人组蛋白 H1、H2A、H2B、H3 和 H4 诱导血小板激活的能力以及可能涉及的分子机制。所有组蛋白都是血小板黏附和铺展的底物,并触发纤维蛋白原结合、聚集、血管性血友病因子释放、P-选择素和磷脂酰丝氨酸(PS)暴露以及血小板-白细胞聚集的形成;然而,H4 是最有效的。组蛋白介导的纤维蛋白原结合、P-选择素和 PS 暴露以及混合聚集的形成被凝血酶增强。组蛋白诱导 ERK、Akt、p38 和 NFκB 的激活。因此,用 ERK(U 0126)、PI3K/Akt(Ly 294002)、p38(SB 203580)和 NFκB(BAY 11-7082 和 Ro 106-9920)抑制剂预处理血小板可显著抑制组蛋白诱导的血小板激活。用阿司匹林或地塞米松预处理血小板可显著减少纤维蛋白原结合和组蛋白介导的黏附,而不影响 P-选择素暴露。H3 和 H4 诱导的血小板功能反应,而不是 H1、H2A 和 H2B,部分通过与 Toll 样受体 -2 和 -4 相互作用介导。我们的数据表明组蛋白是止血和促炎血小板反应的重要触发因素,只有止血反应部分被抗炎药物抑制。